Question about valuation for CIPs

I was on a deal where we had to analyze a manufacturing company that focuses on vitamin supplements. For my deal, we focused a lot on the qualitative aspects of the business IE competitive positioning, SKU growth, expanded position in market over time, etc. However, in terms of valuation all we did was a DCF, which we just presented management's numbers with no sensitivity analysis done. We also did not do an LBO, precedent transaction, or comparable companies analysis. I just wanted to see if this was common in banking because I am not sure if I am 1) being dupped in my experience as an analyst or 2) the company is just so doo-doo that only a DCF is needed.

For reference as to why I am asking, I am trying to lateral into another investment bank and want to demonstrate my modeling experience (or lack thereof tbh). If my only exposure so far is this one deal with this one model in terms of my modeling experience, will that suffice? I'm hoping my shorter tenure will excuse the lack of modeling on my job.